SPY333.76-1.81 -0.54%
DIA277.96-0.18 -0.06%
IXIC10,827.60-140.76 -1.28%

Syndax Pharmaceuticals Q3 EPS $(0.41) Beats $(0.47) Estimate, Sales $379K Beat $370K Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.47) by 12.77 percent. This is a 39.71 percent increase over losses of $(0.68) per share

Benzinga · -

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.47) by 12.77 percent. This is a 39.71 percent increase over losses of $(0.68) per share from the same period last year. The company reported quarterly sales of $379 thousand which beat the analyst consensus estimate of $370 thousand by 2.43 percent. This is the same as the same period last year.